Plasvacc USA Inc

What Plasvacc USA Inc does

Plasvacc USA Inc is a privately held US-based veterinary biological products company that manufactures hyperimmunized plasma and related blood products for equine and canine patients. The company's core technology is hyperimmunization: donor animals are immunized to reach USDA-specified antibody levels, and the resulting high-IgG, cell-free plasma is never blended and is fully traceable to a single donor. Operations are anchored by a USDA-licensed facility with a quarantined donor herd of approximately 90 horses, using pheresing equipment comparable to human blood collection standards.

The product portfolio is anchored by two registered trademarks: Equiplas® (equine hyperimmunized plasma) and Caniplas® (canine hyperimmunized plasma), supplemented by Equine Whole Blood, diagnostic kits across equine/canine/feline species, lab services, and the Flexineb respiratory device. The company emphasizes label-level IgG transparency as a customer-facing quality claim.

Plasvacc operates a direct-to-veterinarian B2B sales motion, with ordering by phone (+1-800-654-9743) and website, and technical support staffed by practicing veterinarians. The branded commercial footprint extends to affiliated Plasvacc sites in Australia, the UK, and Chile. The company is privately held with no disclosed institutional investors, funding rounds, or revenue figures. Customer segments are veterinary practices — primarily equine healthcare providers and secondarily canine healthcare providers — with no public enterprise customer disclosures and pricing conducted on a quote basis.

Name

Plasvacc USA Inc

Legal name

Plasvacc USA Inc

Website

https://plasvaccusa.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Plasvacc USA Inc is a privately held, USDA-licensed veterinary biological products manufacturer that produces hyperimmunized plasma (Equiplas®, Caniplas®) and whole blood from a quarantined donor herd for equine and canine veterinary practices.

Ownership category

akta.pro rank

Product category

Veterinary Biological Products

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biologics & Immunotherapies (Non-vaccine) (HLAMAEAK)

akta.pro secondary industries

Equine Therapeutics (Rx) (HLAMAEAC), Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH)

Keywords

• Veterinary plasma products
• Hyperimmunized plasma therapy
• Equine blood products
• Canine plasma biologics
• Veterinary biological products

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Veterinary Plasma Products: Sale of hyperimmunized plasma products for veterinary use including equine and canine applications. Products include Equiplas, Caniplas, Equine Whole Blood, and related diagnostic and lab products.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Plasvacc USA Inc manufactures and sells hyperimmunized, cell-free veterinary plasma biologics for equine (Equiplas®) and canine (Caniplas®) use, along with equine whole blood, diagnostic kits, laboratory testing services, and respiratory therapy devices. Products are made at a USDA-licensed facility from a quarantined, USDA-approved donor herd of approximately 90 horses using pheresing equipment comparable to human blood collection, with single-source traceability and IgG antibody levels printed on labels.

Product overview

Plasvacc USA is a veterinary biological products company offering a portfolio of hyperimmunized, cell-free plasma products for animals. The core product line centers on two branded plasma products: Equiplas® for equine use and Caniplas® for canine use, both featuring high gamma globulin (IgG) levels and USDA-licensed certification. Supporting offerings include Equine Whole Blood from a donor herd of approximately 90 horses, Diagnostic Kits across equine/canine/feline species, Lab Services, and Flexineb respiratory devices. The company operates a USDA-licensed facility using pheresing equipment similar to human blood collection, with all products featuring single-source traceability and never-blended plasma.

Differentiator

Problem solved

Functional benefit

Brands

• Equiplas®: USDA-licensed equine plasma product with high IgG antibody levels for natural healing in horses
• Caniplas®

Products and services

• Equiplas® Hyperimmunized equine plasma product with high gamma globulin (IgG) antibody levels, USDA-licensed, with IgG measurements displayed on labels. Designed for equine veterinarians and clinics administering plasma therapy for immunity, protection, and recovery in horses.
• Caniplas® Hyperimmunized canine plasma product offering high antibody levels for immunity and healing; single-source, cell-free, and never blended. Designed for canine veterinary practitioners and clinics treating dogs with conditions requiring elevated antibody support.
• Equine Whole Blood Whole blood product collected from Plasvacc's USDA-approved donor herd of approximately 90 horses for equine transfusion needs. Intended for equine veterinarians performing transfusion procedures.
• Diagnostic Kits Diagnostic testing kits for equine, canine, and feline health assessment offered by Plasvacc USA. Sold to veterinary clinics and practices for point-of-care and laboratory diagnostic use.
• Lab Services Laboratory testing services supporting equine health diagnostics and plasma product analysis. Provided to veterinarians and clinics requiring specialized testing beyond in-clinic capabilities.
• Flexineb Nebulizer device for equine respiratory therapy, supporting treatment delivery for respiratory conditions in horses. Offered by Plasvacc USA to equine veterinary practitioners.

Quantifiable outcome

• Guaranteed higher IgG levels compared to non-hyperimmunized products

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered minor.

• AAEP (American Association of Equine Practitioners)minorOthersProfessional membership organization for equine veterinarians. Plasvacc is a proud member, supporting the equine veterinary community.
• AA EVTminorOthersProfessional veterinary technology association. Plasvacc holds membership supporting the veterinary technology community.
• AVHTMminorOthersAssociation of Veterinary Holistics and Traditional Medicine. Plasvacc membership supports integrative veterinary medicine practitioners.
• VECCSminorOthersVeterinary Emergency and Critical Care Society. Plasvacc supports emergency and critical care veterinary professionals through membership.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Virbac: Global animal health company with veterinary specialty pharmaceuticals including equine products. Comparable B2B veterinary sales motion and equine focus, though broader in therapeutic categories.
• Elanco Animal Health: Major global animal health company with companion animal and equine therapeutics. Comparable in veterinary channel and biologics presence, though much larger and broader in product scope.
• Vetoquinol: Global veterinary pharmaceutical company with a strong equine portfolio. Comparable in targeting equine veterinary practices with specialty therapeutics, though far larger and broader in product scope than Plasvacc.
• Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company with equine and companion animal therapeutic lines. Comparable end customers (veterinary practices) and specialty pharma positioning, though plasma is not a core product.
• Zoetis: Largest global animal health company with extensive equine and companion animal biologics portfolios. Overlaps with Plasvacc in equine veterinary biologics and plasma-derived products, though as part of a much wider portfolio.
• Boehringer Ingelheim Animal Health: Global animal health division of Boehringer Ingelheim with veterinary biologics and equine products. Overlaps in biologics category and veterinary channel, though operates at vastly larger scale and broader portfolio.

Direct peers

• Lake Immunogenics: Manufacturer of hyperimmune plasma products for small and large animals. Comparable product technology (hyperimmunized plasma) and similar veterinary distributor channel, though broader species coverage.
• Veterinary Immunogenics: UK-based producer of hyperimmune equine plasma products for veterinary use. Most directly comparable peer — same hyperimmunized plasma technology, same equine veterinary customer base, and overlapping UK/US distribution.

Emerging players

• Ardent Animal Health: Veterinary plasma and blood product supplier for animal health applications. Comparable in product category (animal plasma products) and customer base (veterinary practices).
• IDEXX Laboratories: Major veterinary diagnostics company that also offers equine-focused diagnostic and lab services. Comparable in the diagnostic kits and lab services adjacencies Plasvacc offers alongside its core plasma products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/259883219029667
• LinkedInlinkedin.com/company/plasvacc-usa-inc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Plasvacc USA Inc